Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in Middle East in May 2025

Last updated: May 2025 A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in Middle east. We rank investors based on the number of investments they made in Medical device companies from Middle east. We update this investor list every month.

Top 50 Medical Device Startup Investors in Middle East in May 2025

Investor	Medical Device Middle East investments
Israel Innovation Authority	8
Pontifax	8
Diffusion Capital Partners	8
Trendlines Group	7
OurCrowd	5
Accelmed	5
J-Ventures	4
Elron Ventures	4
Btomorrow Ventures	4
Agriline	4
Rimonci Capital	3
Longevity Venture Partners	3
Triventures	3
OrbiMed	3
Docor International Management	3
OTV	3
Eczacıbasi Momentum	3
Sofinnova Partners	2
Maccabi Fund	2
Zohar Gilon	2
Johnson & Johnson Robotics and Digital Solutions	2
MTIP AG	2
Shimon Eckhouse	2
Emerge Ventures	2
Kli Capital	2
Rapha Capital Management	2
Terra Venture Partners	2
Medtronic	2
Smith & Nephew	2
Ron C	2
GlenRock Israel	2
Mazal CB	2
Mithril Capital Management	2
TT Ventures	2
Prof. Rafael Beyar	2
TechWald Holding S.p.A.	2
Consensus Business Group	2
Boston Scientific	2
Robin Hood Ventures	2
The Chartered Group	2
Keiretsu Forum Northwest	2
Indaco Venture Partners	2
ZORA Ventures	2
Turkey Development Fund	2
Eclipse Ventures	2
Israel Biotech Fund	2
Yehuda Zisapel	2
Italian Angels for Growth	2
HealthpointCapital	2
Merz Therapeutics	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Investment focus

Health Care, Medical Device, Biotechnology
Grant, Seed, Pre-Seed
Israel, United States, Mali

Portfolio highlights

i-EcoGuard — I-Ecoguard is pioneering sustainable agriculture with cutting-edge nanoparticle technology. Our objective is to improve greenhouse efficiency, plant health, and crop quality.
Eretz Angels — Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.
Lowental Hybrid — Lowental Hybrid technology combines fuel-based propulsion with electric power, enabling longer operating hours while preserving the low noise levels characteristic of electric systems.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Lutris Pharma — Improving anti-cancer therapy by reducing dose limiting side effects
Indapta Therapeutics — Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.

Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.

Investment focus

Software, Information Technology, SaaS
Seed, Series A, Funding Round
Turkey, United States, United Kingdom

Portfolio highlights

Khenda — Khenda is an AI-based video analytics platform that helps manufacturing plants to increase their safety, efficiency, and quality at production lines by analyzing manual activities.
Enhencer — Reach AI based transparent audiences or lookaliles for your ecommerce. Achieve higher campaign conversion and ROAS than ever before.
Gowit Technology — GoWit is a leading AdTech company, specializing in a multi-channel Retail Media Ads platform for online retailers. Our main objective is to empower businesses with comprehensive advertising solutions and maximize ad monetization. To reach a broader audience, we offer a variation of on-site & off-site advertising options such as SponsoredProducts, Sponsored Brands, Display, Video and In-Store Ads. With a clear focus on transparency, we are committed to helping our partners establish a powerful presence in the ever-growing world of retail.

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Investment focus

Biotechnology, Health Care, Medical Device
Seed, Funding Round, Series A
Israel, Singapore, United Kingdom

Portfolio highlights

AgriG8 — AgriG8 is an enterprise designed to align, collaborate, de-risk and grow value chains and ecosystems within the agricultural industry.
Peptobiotics — We make agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new new type of antibiotic alternative that does not cause resistance. Our recombinant peptides are synthetic biology products manufactured in a patent pending precision fermentation process. We are launching a range of products across livestock and aquaculture in Asia.
Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.

Access exclusive venture capital angel investment deals in pre-vetted startup companies. Create your free OurCrowd investor account today!

Investment focus

Software, Artificial Intelligence, Machine Learning
Series B, Series A, Seed
Israel, United States, New Zealand

Portfolio highlights

Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
Kando — Kando is an end-to-end solution that creates continuous awareness of events in the collection system. Kando enables utilities to remotely and continuously improve their operations by providing the following features:• Realtime wastewater quality data across the collection system • Pinpoint sources of pollution • Early warnings of damaging WWTPinfluent quality • Machine learning that evolves with your network • Autonomous sampling units • User fee calculator • Customized pollution alerts • A user-friendly, online interface • Detection of COVID-19 infection rates (New)The combination of these actionable insights results in:• Reduced CAPEX/OPEX • Greater WW reuse capabilities • Improved public health • Cleaner environmentsKando has been deployed in Los Angeles, Milan, Brisbane, and many other cities. To gain a greater understanding of how our system can help your organization, visit our homepage at www.kando.eco.
Blue Tree Technologies Ltd. — Blue Tree’s mission is to develop a sugar reduction platform for industrial applications in the drinks industry.

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Investment focus

Health Care, Medical Device, Medical
Funding Round, Series A, Series D
Israel, United States

Portfolio highlights

Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
Click Therapeutics — We combine neuroscience with the power of software to create patient-centric digital treatments. Discover our prescription digital therapeutics and software-enhanced drug therapies.

J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more. Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.

Investment focus

Software, Health Care, Machine Learning
Series A, Seed, Pre-Seed
United States, Israel

Portfolio highlights

Epic Cleantec — Epic Cleantec provides sustainable onsite wastewater reuse solutions for the built environment
Onebeat — Onebeat helps retailers, wholesalers, and brands achieve results through operational optimization. It offers solutions for the needs of the technology of retail. It develops platforms that aim to help businesses optimize how they handle their retail. It's headquarters is in Petach Tikva in Israel and it has branches globally.
Oso Semiconductor — A New Approach to RF Beamforming

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

Investment focus

Information Technology, Health Care, Software
Seed, Series A, Funding Round
Israel, United States, China

Portfolio highlights

Creednz — Creednz is a company that provides financial data management system that involves internal financial data sets.
Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.

Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.

Investment focus

Health Care, Wellness, Food and Beverage
Series A, Seed, Series B
United States, United Kingdom, India

Portfolio highlights

Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.

Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.

Investment focus

Health Care, Medical Device, Medical
Seed, Funding Round, Series A
Israel

Portfolio highlights

Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.

A dedicated to China-Israel cross border investment.

Investment focus

Health Care, Medical Device, Eyewear
Series A, Seed, Series B
Israel, France, United States

Portfolio highlights

EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
TECLens — TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, andmore.
Laclarée — Laclarée develops a pair of adaptive eyeglasses for presbyopia. Its patented technology allows the eyeglasses to adapt in real-time to the scene viewed by the wearer. This major innovation will help milllions of people 45+ years, who are not satisfied with current solutions (progressive lenses, multiple pairs, etc...).

Longevity Venture Partners is an early-stage venture capital firm committed to assisting entrepreneurs in the Silvertech, Healthcare, and Wellness sectors.

Investment focus

Health Care, Medical Device, mHealth
Seed, Pre-Seed, Series A
Israel, United States

Portfolio highlights

Faireez — Optimizing tenants' lifestyle and convenience through enabling them with a hotel-like home cleaning service
FertilAI — FertilAI is a healthcare company developing technologies that improve the success rate of fertility treatments, elevate the patient experience, and increase clinics ability to scale. The company’s AI algorithms automate the process and assist physicians in making the best clinical decisions during treatments. The algorithms are seamlesslyintegrated into the company’s Fertilane platform. This allows effective communication between clinics, doctors, and patients using doctor/patient apps and admin webapps tailor made for the fertility workflows. FertilAI is based in Israel and was founded by a collaboration of technology experts and leading REIs including Prof. Ariel Hourvitz, Dr. Ettie Maman, and Dr. Micha Baum.
Exero Medical — Exero Medical is a medical device manufacturing company. It develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI Surgery. Its system is designed to prevent complications by warning physicians of a potential leak, enabling early intervention.The company was founded in 2018 and is headquartered in OrYehuda, Israel.

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Investment focus

Health Care, Medical Device, Medical
Funding Round, Series A, Series B
United States, Israel, Ireland

Portfolio highlights

Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
TailorMed — Moving Mountains for Patients

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

RayThera — RayThera specializes in developing breakthrough small molecule therapies for critical unmet needs in immunology. Backed by decades of drug discovery expertise, we accelerate the development process while maintaining rigorous standards.
Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
Edgewise Therapeutics — See how we bring our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases.

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Funding Round, Series C, Series A
Israel, United States

Portfolio highlights

Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.

OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.

Investment focus

Health Care, Medical, Artificial Intelligence
Series A, Series B, Seed
United States, Israel, Ghana

Portfolio highlights

Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.

Eczacıbaşı Momentum invested in three venture companies and a venture capital fund; Their goal is to invest US$30 million over the next five years as they continue to partner with funds and startups that shape the new normal of modern life, focusing on well-being, consumption, and home-living.

Investment focus

Medical Device, Information Technology, Neuroscience
Seed, Series A, Funding Round
Turkey, United States

Portfolio highlights

Newlab — Systems for scale
Ecomercek — Ninico is a modern and flexible Minimal eCommerce Laravel script. This script is suited for electronic, organic and grocery store, furniture store, clothing store, hitech store and accessories store...
RS Research — RS Research is a next generation therapeutics company developing novel nanomedicines. We have developed a pioneering class of nanocarriers with which we currently have proprietary programs in various stages of preclinical development for treatment of cancer.Our nanocarrier platform is highly tunable with a plug & play approach, allowingspeedy development of targeted nanomedicines with superior performance.Along with moving our very own candidates toward clinic, we provide preclinical services to industrial and academic partners. We have specific expertise in biosimilar characterization as well as in vivo experiment design.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.

Maccabi Fund is an investment fund.

Investment focus

Health Care, Medical Device, Artificial Intelligence
Seed, Pre-Seed, Series A
Israel, United States

Portfolio highlights

AccuLine — AccuLine is a digital healthcare company, which was founded with the vision to saves the lives of millions of people worldwide.
Rhino Federated Computing — Rhino Health utilizes Federated Learning to improve healthcare AI solutions by providing access to a large, continually updated, distributed dataset from a diverse group of patients, powering AI models that deliver consistent results and improve the standard of care.
Olive Diagnostics — It's About me (IAM) has developed a passive sensor mounted to the rim of the toilet that performs urinalysis every time the end-user urinates. The information is uploaded to a robust data science platform to track existing and progressing conditions. Real-time, actionable notifications will be sent to the end user for proactive medical ornutritional care. Ongoing biomarker tracking for hydration, Alcohol, Pregnancy, Ovulation, Keytones, etc. is used to develop a comprehensive personal user profile.The technology will also be used for pharma and CRO companies to track the usage of drugs. While drug compliance issues plague health care systems around the world, I AM's technology will provide a reliable and continuous solution for tracking when and how people take their medicine or clinical trial drug.Nonindustrial nations will now have home access to urine lab services.

Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.

Investment focus

Software, Internet, Health Care
Seed, Series A, Series B
Israel, United States

Portfolio highlights

CADY — CADY utilizes AI technology to automate the analysis of electrical schematics
Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.

Healthcare innovation wherever it originates.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Israel, United Kingdom

Portfolio highlights

Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!

Investment focus

Health Care, Artificial Intelligence, Medical
Series A, Series B, Series C
United States, United Kingdom, Spain

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.

Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging. He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.

Investment focus

Health Care, Medical Device, Medical
Series B, Series C, Funding Round
Israel

Portfolio highlights

Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
RealView Imaging — RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for Augmented Reality applications.

Emerge is an early stage, Tel-Aviv based Venture Capital firm, partnering with exceptional tech-innovators and helping them do whatever it takes to win.

Investment focus

Software, Artificial Intelligence, Information Technology
Series A, Seed, Series B
Israel, United States

Portfolio highlights

Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
Stigg — Use Stigg's software and APIs to get easy fine-tuned control over what can be priced and packaged separately. Rapidly tweak, test and roll-out your pricing and packaging with no-code.
Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.

Kli Capital is a firm focused on investing in fearless entrepreneurs who are building foundational enterprise technologies and ubiquitous consumer brands. We partner with exceptional founders with unique insights, from inception through all phases of growth.

Investment focus

Health Care, Software, Wellness
Seed, Funding Round, Series A
United States, Israel, Mexico

Portfolio highlights

LexCheck — Transform your contract negotiation process with AI. Review, redline and approve contracts quickly and economically with the power of automation.
VersusGame — VersusGame offers creators and brands the opportunity to cultivate a community with an interactive content solution that rewards knowledge
Cooper — Your parenting lifeline.

Rapha Capital Management focused on identifying and growing revolutionary ideas in medicine, healthcare and technology before others can see their value. For inquiries, telephone and contact details are used.

Investment focus

Health Care, Therapeutics, Biotechnology
Series A, Series C, Post-IPO Debt
United States, Israel

Portfolio highlights

FIZE Medical — FIZE Medical offers the first platform technology to remotely monitor and manage patients with an indwelling Foley catheter. Learn more about us >>
Imagin Medical — Imagin Medical is a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The Company’s initial focus is bladder cancer.The i/Blue Imaging System™ is expected to dramatically improve physicians’ ability to visualize cancerous cells. Working in conjunction withfluorescing imaging agents, this advanced, ultrasensitive imaging technology combines sophisticated opto-electronic functions and near-infrared fluorescence to deliver images far superior to conventional white light systems. Display options include separate blue or white light images, blue and white images displayed side-by-side, or a blending of the blue and white light images into one. Imagin believes the time savings will increase the efficiency of the operating room and potentially reduce healthcare costs by enabling procedures to be performed in the less expensive physician’s office.The i/Blue system was invented by Dr. Stavros Demos at the Lawrence Livermore National Laboratory (LLNL) and validated in collaboration with the UC Davis Comprehensive Cancer Center and Dr. Ralph deVere White, one of the world’s leading authorities on bladder cancer. Imagin now holds the exclusive license to this intellectual property and relocated the final stage of development to the highly-regarded University of Rochester Laboratory for Laser Energetics (LLE) and its affiliated first-class Medical Center. A Research Study using the i/Blue Imaging System prototype was led by Dr. Edward Messing and provided valuable input to the development of the final product for commercialization. Imagin’s engineering team has completed the Proof of Concept Phase and expects the Functional Phase to be completed by end of 2Q2019.As the i/Blue Imaging System becomes established in the urology market, the Company will complete development of the i/Vision Imaging System technology which combines multiple illumination sources into one system. The i/Vision will accommodate the most commonly used fluorescing contrast agents and will potentially enable Imagin to expand into additional surgical specialties.
AsclepiX Therapeutics — AsclepiX Therapeutics is focused on transforming the treatment of ocular diseases through the rapid clinical development of groundbreaking therapies aimed at empowering patients and their families around the world with...

We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies

Investment focus

Artificial Intelligence, Machine Learning, Software
Seed, Series A, Series B
Israel, United States

Portfolio highlights

ViewNetic — ViewNetic is an AgTech company that develops imaging and machine learning technologies for the early detection of pests and diseases in crops. It aims to develop autonomous high-resolution IPM systems to provide growers with detailed mapping of pests, benefits, and diseases and provide treatment recommendations to enable reduced chemical and laboruse, and improve crop quality and efficiency.The company was founded in 2018 and is headquartered in Yokneam, Illit, Israel.
Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
Intuition Robotics — The AI care companion robot for older adults

Medtronic develops healthcare technology to treat chronic diseases. Its medical technology is providing lifelong solutions for people with chronic pain. The company is committed to improving lives through its medical technologies, services, and solutions. Medtronic has four main business units: the Minimally Invasive Therapies Group, the DiabetesGroup, the Restorative Therapies Group, and the Cardiac and Vascular Group. Medtronic develops and manufactures devices and therapies to treat more than 30 chronic diseases that include heart failure, Parkinson disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders, and diabetes.Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States

Investment focus

Health Care, Medical Device, Medical
Series C, Funding Round, Series B
United States, Israel, China

Portfolio highlights

FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
CathWorks — CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFRangio based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits forpatients with coronary artery disease and economic benefits for patients and payers. The company’s focus is specifically on bringing the CathWorks FFRangio System to market to provide quick, precise, and objective intraprocedural FFRangio guidance that is practical for every case.
Avation Medical — 42 million men and women have symptoms of OAB and incontinence. Vivally can help.

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Investment focus

Medical Device, Medical, Health Care
Series B, Series C, Funding Round
Israel, United States, United Kingdom

Portfolio highlights

OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
Michelson Diagnostics — Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 Âµm resolution,in real time, to depths of 1 mm or more.

Ron C

Investment focus

Health Care, Therapeutics, Medical Device
Seed, Pre-Seed
Israel

Portfolio highlights

DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Investment focus

Software, Cyber Security, Transportation
Seed, Series B, Series A
Israel, United States

Portfolio highlights

Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.

Mazal CB

Investment focus

Health Care, Therapeutics, Medical Device
Seed, Pre-Seed
Israel

Portfolio highlights

DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.

Mithril is a family of long-term venture capital funds agnostic to sector and geography. We invest and partner with teams who use technology to build valuable and lasting businesses, often in industries long overdue for change.

Investment focus

Software, Health Care, Information Technology
Series C, Series B, Series D
United States, United Kingdom, Israel

Portfolio highlights

Neocis — Yomi, a dental robot, is the next generation in implant surgery that can give patients a better experience, expand your offerings and boost your efficiency
Genetesis — Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened.
Juno — On-ramp to more than 20 chains with no holding period on crypto withdrawals

Corporate venture capital arm of Turk Telekom

Investment focus

Software, Information Technology, EdTech
Seed, Pre-Seed, Series A
Turkey, United Kingdom, Germany

Portfolio highlights

DTCP — DTCP is an investment management firm focused on growth equity and digital infrastructure. Founded in 2015, the firm has raised more than $1 billion in funds from corporate and institutional investors and invested in over 60 companies. DTCP Growth invests in enterprise application and infrastructure software companies. DTCP Infra invests in mobileaccess, fiber, and data center infrastructure. DTCP is headquartered in Hamburg with offices in Menlo Park, Tel Aviv, and Seoul.
B2Metric — B2Metric is an AI-powered predictive data analytics solution that optimizes your marketing budget by understanding customer journey behavior
MentalUp — Educational games for kids of all ages. Choose from over 150+ fun and engaging award-winning games. Easy-To-Use. 100% Free + No Ads. Play Now!

Prof. Rafael Beyar

Investment focus

Medical, Medical Device, Machine Learning
Seed, Series A
Israel

Portfolio highlights

MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).

TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Series C
Israel, United States

Portfolio highlights

SoniVie — SoniVie's lead product, TIVUS, is an investigational intravascular treatment that can be performed as part of a routine right heart catheterization for patients suffering from pulmonary arterial hypertension (PAH)
SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

Investment focus

Health Care, Medical Device, Biotechnology
Funding Round, Seed, Series B
Israel, United States, United Kingdom

Portfolio highlights

BioProtect — Discover the Difference Fill out the fields below and a member of our team will contact you to set up a demo. Visualize the Space Optimize prostate radiatio ...
Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
RepAir — RepAir develops a Direct Air Capture system based on a proprietary electrochemical cell technology that can capture CO2 from the air in gigaton scale. Powered solely by renewable energy, our system can be deployed at the site of carbon storage or utilizations, saving arable land and avoiding CO2 transport.

Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.

Investment focus

Health Care, Medical Device, Biotechnology
Series B, Series C, Series D
United States, Israel, Canada

Portfolio highlights

Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
Nectero Medical — Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
4C Medical Technologies — 4C Medical Technologies is a medical device company that develops minimally invasive therapies for structural heart disease. It preserves the native mitral valve and left ventricle, eliminating known issues associated with transcatheter mitral valve replacement technologies that rely on placement and fixation in the native mitral annulus and leftventricle.It was founded in 2015 and headquartered in Maple Grove, Minnesota.

Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.

Investment focus

Software, Health Care, Biotechnology
Seed, Series A, Funding Round
United States, Israel

Portfolio highlights

Vytala — Vytala is a food tech firm focused on improving nutrition through innovative solutions.
Proscia — Proscia is a software company that is changing the way the world practices pathology to transform cancer research and diagnosis. With the company’s Concentriq digital pathology platform and pipeline of AI-powered applications, laboratories are leveraging new kinds of data to accelerate discoveries and improve patient outcomes. Proscia’s team oftechnologists, scientists, and pathologists is bringing a fresh approach to an outdated industry, helping the world to keep pace with the increasing demand for pathology services and fulfill the promise of precision diagnostics.
S2N Health — Our superior healthcare data, industry expertise, and embedded AI inject critical intelligence into commercial workflows to drive efficient growth.

The Chartered Group is an investment platform.

Investment focus

Biopharma, Agriculture, Health Care
Funding Round, Series A, Private Equity
Israel

Portfolio highlights

Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.

Keiretsu Forum is a community of private equity investors, business leaders and entrepreneurs with a network of over 50 global chapters and more than 2,500 investor members.

Investment focus

Health Care, Software, Biotechnology
Series A, Seed, Funding Round
United States, Spain, Canada

Portfolio highlights

iQure Pharma — iQure Pharma preclinical and clinical drug development
Levered Learning — Levered Learning is a classroom-tested and teacher-designed instructional system providing 3rd-5th grade mathematical learning. The company was founded in 2017 by Mitch Slater and is headquartered in Soquel, California, United States.
Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Funding Round
Italy, United States, United Kingdom

Portfolio highlights

Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Investment focus

Health Care, Biotechnology, Internet
Seed, Series A, Convertible Note
Israel, United States, United Kingdom

Portfolio highlights

BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.

Turkey Development Fund aims to develop the enterprise ecosystem by investing in new generation startups.

Investment focus

Information Technology, Software, SaaS
Series A, Seed, Series B
Turkey, United Kingdom

Portfolio highlights

Rnv.ai — RNV Analytics provides AI and ML driven solutions for inventory allocation problem of retail companies. With algorithmics recommendation, their customers decide which product should be located in which sales points both online and offline.
Delivers.AI — Delivery droid operator
Eatron Technologies — Intelligent Software Platform for Battery Management System & Intelligent Motion Control - Eatron Technologies

Palo Alto based Eclipse Ventures partners with entrepreneurs boldly transforming the essential industries that define and propel economies. Learn more.

Investment focus

Software, Robotics, Artificial Intelligence
Series A, Series B, Seed
United States, Canada, Israel

Portfolio highlights

Gravity — Gravity Climate provides a software platform designed for carbon management, specifically tailored for industrial businesses and their supply chain partners. The platform helps companies measure, manage, and reduce their carbon emissions, facilitating a clear and actionable climate strategy. Gravity Climate's tools support decarbonizationefforts by streamlining carbon accounting processes and offering insights to advance industrial sustainability goals.
AheadComputing — AheadComputing is a company that specializes in designing, licensing, and providing support for high-performance microprocessor cores and related technologies.
Starboard — Starboard revolutionize global trade by empowering SMB freight forwarders with cutting-edge AI tools.

Israel Biotech Fund – Building the future of Israeli BiotechIsrael Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies.Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages.Ourpartners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance.We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series B, Series A, Series C
Israel, United States

Portfolio highlights

MediWound — MediWound is a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration.
Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.

Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.

Investment focus

Medical Device, Medical, Health Care
Funding Round, Series A, Seed
Israel

Portfolio highlights

Carteav — Autonomous Low Speed Vehicle
Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Investment focus

Software, E-Commerce, Health Care
Seed, Angel, Series A
Italy, United States, United Kingdom

Portfolio highlights

ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.

HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.

Investment focus

Medical, Biotechnology, Manufacturing
Series B, Series C, Funding Round
Israel, United States

Portfolio highlights

OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!

Merz Therapeutics is dedicated to improving the lives of patients around the world with its relentless research, development, and culture of innovation. Merz Therapeutics strives to serve unmet patient needs and realize better outcomes.

Investment focus

Health Care, Therapeutics, Medical Device
Corporate Round
Israel

Portfolio highlights

Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.

Investors by industry

Artificial intelligence